 | • レポートコード：MRC2312MG00042 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のフォスタマチニブ錠剤市場規模と予測を収録しています。・世界のフォスタマチニブ錠剤市場：売上、2018年-2023年、2024年-2029年 ・世界のフォスタマチニブ錠剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のフォスタマチニブ錠剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「100mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 フォスタマチニブ錠剤のグローバル主要企業は、Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、フォスタマチニブ錠剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のフォスタマチニブ錠剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のフォスタマチニブ錠剤市場：タイプ別市場シェア、2022年 ・100mg、150mg 世界のフォスタマチニブ錠剤市場：用途別、2018年-2023年、2024年-2029年 世界のフォスタマチニブ錠剤市場：用途別市場シェア、2022年 ・慢性免疫性血小板減少症（ITP）、ヴァルデンシュトレームマクログロブリン血症、自己免疫性溶血性貧血、その他 世界のフォスタマチニブ錠剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のフォスタマチニブ錠剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるフォスタマチニブ錠剤のグローバル売上、2018年-2023年 ・主要企業におけるフォスタマチニブ錠剤のグローバル売上シェア、2022年 ・主要企業におけるフォスタマチニブ錠剤のグローバル販売量、2018年-2023年 ・主要企業におけるフォスタマチニブ錠剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca ************************************************************* ・調査・分析レポートの概要 フォスタマチニブ錠剤市場の定義 市場セグメント 世界のフォスタマチニブ錠剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のフォスタマチニブ錠剤市場規模 世界のフォスタマチニブ錠剤市場規模：2022年 VS 2029年 世界のフォスタマチニブ錠剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのフォスタマチニブ錠剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のフォスタマチニブ錠剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：100mg、150mg フォスタマチニブ錠剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：慢性免疫性血小板減少症（ITP）、ヴァルデンシュトレームマクログロブリン血症、自己免疫性溶血性貧血、その他 フォスタマチニブ錠剤の用途別グローバル売上・予測 ・地域別市場分析 地域別フォスタマチニブ錠剤市場規模 2022年と2029年 地域別フォスタマチニブ錠剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca ... |
This research report provides a comprehensive analysis of the Fostamatinib Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fostamatinib Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fostamatinib Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Fostamatinib Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fostamatinib Tablets market presents opportunities for various stakeholders, including Chronic Immune Thrombocytopenia (ITP), Waldenström’s Macroglobulinemia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fostamatinib Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fostamatinib Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Fostamatinib Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fostamatinib Tablets market.
Market Overview: The report provides a comprehensive overview of the Fostamatinib Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 100 mg, 150 mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fostamatinib Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fostamatinib Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fostamatinib Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fostamatinib Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fostamatinib Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fostamatinib Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fostamatinib Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fostamatinib Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fostamatinib Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
100 mg
150 mg
Market segment by Application
Chronic Immune Thrombocytopenia (ITP)
Waldenström’s Macroglobulinemia
Autoimmune Haemolytic Anaemia
Other
Global Fostamatinib Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Rigel Pharmaceuticals
Kissei Pharmaceutical
Grifols
JW Pharmaceutical Corporation
Medison Pharma Canada
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fostamatinib Tablets, market overview.
Chapter 2: Global Fostamatinib Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Fostamatinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fostamatinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fostamatinib Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fostamatinib Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fostamatinib Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fostamatinib Tablets Overall Market Size
2.1 Global Fostamatinib Tablets Market Size: 2022 VS 2029
2.2 Global Fostamatinib Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fostamatinib Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Fostamatinib Tablets Players in Global Market
3.2 Top Global Fostamatinib Tablets Companies Ranked by Revenue
3.3 Global Fostamatinib Tablets Revenue by Companies
3.4 Global Fostamatinib Tablets Sales by Companies
3.5 Global Fostamatinib Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fostamatinib Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fostamatinib Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fostamatinib Tablets Players in Global Market
3.8.1 List of Global Tier 1 Fostamatinib Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Fostamatinib Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fostamatinib Tablets Market Size Markets, 2022 & 2029
4.1.2 100 mg
4.1.3 150 mg
4.2 By Type – Global Fostamatinib Tablets Revenue & Forecasts
4.2.1 By Type – Global Fostamatinib Tablets Revenue, 2018-2023
4.2.2 By Type – Global Fostamatinib Tablets Revenue, 2024-2029
4.2.3 By Type – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Fostamatinib Tablets Sales & Forecasts
4.3.1 By Type – Global Fostamatinib Tablets Sales, 2018-2023
4.3.2 By Type – Global Fostamatinib Tablets Sales, 2024-2029
4.3.3 By Type – Global Fostamatinib Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Fostamatinib Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fostamatinib Tablets Market Size, 2022 & 2029
5.1.2 Chronic Immune Thrombocytopenia (ITP)
5.1.3 Waldenström’s Macroglobulinemia
5.1.4 Autoimmune Haemolytic Anaemia
5.1.5 Other
5.2 By Application – Global Fostamatinib Tablets Revenue & Forecasts
5.2.1 By Application – Global Fostamatinib Tablets Revenue, 2018-2023
5.2.2 By Application – Global Fostamatinib Tablets Revenue, 2024-2029
5.2.3 By Application – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Fostamatinib Tablets Sales & Forecasts
5.3.1 By Application – Global Fostamatinib Tablets Sales, 2018-2023
5.3.2 By Application – Global Fostamatinib Tablets Sales, 2024-2029
5.3.3 By Application – Global Fostamatinib Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Fostamatinib Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fostamatinib Tablets Market Size, 2022 & 2029
6.2 By Region – Global Fostamatinib Tablets Revenue & Forecasts
6.2.1 By Region – Global Fostamatinib Tablets Revenue, 2018-2023
6.2.2 By Region – Global Fostamatinib Tablets Revenue, 2024-2029
6.2.3 By Region – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Fostamatinib Tablets Sales & Forecasts
6.3.1 By Region – Global Fostamatinib Tablets Sales, 2018-2023
6.3.2 By Region – Global Fostamatinib Tablets Sales, 2024-2029
6.3.3 By Region – Global Fostamatinib Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fostamatinib Tablets Revenue, 2018-2029
6.4.2 By Country – North America Fostamatinib Tablets Sales, 2018-2029
6.4.3 US Fostamatinib Tablets Market Size, 2018-2029
6.4.4 Canada Fostamatinib Tablets Market Size, 2018-2029
6.4.5 Mexico Fostamatinib Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fostamatinib Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Fostamatinib Tablets Sales, 2018-2029
6.5.3 Germany Fostamatinib Tablets Market Size, 2018-2029
6.5.4 France Fostamatinib Tablets Market Size, 2018-2029
6.5.5 U.K. Fostamatinib Tablets Market Size, 2018-2029
6.5.6 Italy Fostamatinib Tablets Market Size, 2018-2029
6.5.7 Russia Fostamatinib Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Fostamatinib Tablets Market Size, 2018-2029
6.5.9 Benelux Fostamatinib Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fostamatinib Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Fostamatinib Tablets Sales, 2018-2029
6.6.3 China Fostamatinib Tablets Market Size, 2018-2029
6.6.4 Japan Fostamatinib Tablets Market Size, 2018-2029
6.6.5 South Korea Fostamatinib Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Fostamatinib Tablets Market Size, 2018-2029
6.6.7 India Fostamatinib Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fostamatinib Tablets Revenue, 2018-2029
6.7.2 By Country – South America Fostamatinib Tablets Sales, 2018-2029
6.7.3 Brazil Fostamatinib Tablets Market Size, 2018-2029
6.7.4 Argentina Fostamatinib Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fostamatinib Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fostamatinib Tablets Sales, 2018-2029
6.8.3 Turkey Fostamatinib Tablets Market Size, 2018-2029
6.8.4 Israel Fostamatinib Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Fostamatinib Tablets Market Size, 2018-2029
6.8.6 UAE Fostamatinib Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Rigel Pharmaceuticals
7.1.1 Rigel Pharmaceuticals Company Summary
7.1.2 Rigel Pharmaceuticals Business Overview
7.1.3 Rigel Pharmaceuticals Fostamatinib Tablets Major Product Offerings
7.1.4 Rigel Pharmaceuticals Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Rigel Pharmaceuticals Key News & Latest Developments
7.2 Kissei Pharmaceutical
7.2.1 Kissei Pharmaceutical Company Summary
7.2.2 Kissei Pharmaceutical Business Overview
7.2.3 Kissei Pharmaceutical Fostamatinib Tablets Major Product Offerings
7.2.4 Kissei Pharmaceutical Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Fostamatinib Tablets Major Product Offerings
7.3.4 Grifols Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 JW Pharmaceutical Corporation
7.4.1 JW Pharmaceutical Corporation Company Summary
7.4.2 JW Pharmaceutical Corporation Business Overview
7.4.3 JW Pharmaceutical Corporation Fostamatinib Tablets Major Product Offerings
7.4.4 JW Pharmaceutical Corporation Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.4.5 JW Pharmaceutical Corporation Key News & Latest Developments
7.5 Medison Pharma Canada
7.5.1 Medison Pharma Canada Company Summary
7.5.2 Medison Pharma Canada Business Overview
7.5.3 Medison Pharma Canada Fostamatinib Tablets Major Product Offerings
7.5.4 Medison Pharma Canada Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Medison Pharma Canada Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Fostamatinib Tablets Major Product Offerings
7.6.4 AstraZeneca Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
8 Global Fostamatinib Tablets Production Capacity, Analysis
8.1 Global Fostamatinib Tablets Production Capacity, 2018-2029
8.2 Fostamatinib Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Fostamatinib Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fostamatinib Tablets Supply Chain Analysis
10.1 Fostamatinib Tablets Industry Value Chain
10.2 Fostamatinib Tablets Upstream Market
10.3 Fostamatinib Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fostamatinib Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer